Eissenberg T, Bhatnagar A, Chapman S, Jordt SE, Shihadeh A, Soule EK. Invalidity of an Oft-Cited Estimate of the Relative Harms of Electronic Cigarettes. Am J Public Health 2020; 110: 161-2.
Marynak K, Holmes CB, King BA, Promoff G, Bunnell R, McAfee T, et al. State laws prohibiting sales to minors and indoor use of electronic nicotine delivery systems--United States, November 2014. MMWR Morb Mortal Wkly Rep 2014; 63: 1145-50.
Cooke A, Fergeson J, Bulkhi A, Casale TB. The Electronic Cigarette: The Good, the Bad, and the Ugly. J Allergy Clin Immunol Pract 2015; 3: 498-505.
Lee YH, Chiang T, Kwon E, Baik S, Chang YC. Trends and sociodemographic factors of e-cigarette use among adult daily smokers in South Korea. Int J Health Plann Manage 2020; 35: 960-9.
Bao W, Xu G, Lu J, Snetselaar LG, Wallace RB. Changes in Electronic Cigarette Use Among Adults in the United States, 2014-2016. JAMA 2018; 319: 2039-41.
Filippidis FT, Laverty AA, Gerovasili V, Vardavas CI. Two-year trends and predictors of e-cigarette use in 27 European Union member states. Tob Control 2017; 26: 98-104.
Bowler RP, Hansel NN, Jacobson S, Graham Barr R, Make BJ, Han MK, et al. Electronic Cigarette Use in US Adults at Risk for or with COPD: Analysis from Two Observational Cohorts. J Gen Intern Med 2017; 32: 1315-22.
Layden JE, Ghinai I, Pray I, Kimball A, Layer M, Tenforde MW, et al. Pulmonary Illness Related to E-Cigarette Use in Illinois and Wisconsin - Final Report. N Engl J Med 2020; 382: 903-16.
CDC, Outbreak of Lung Injury Associated with the Use of E-Cigarette, or Vaping, Products [internet] Centers for Disease Control and Prevention. [cited 2021 Dec 15]. Available from https://www.cdc.gov/tobacco/basic_information/e-cigarettes/severe-lung-disease.html.
Nair N, Hurley M, Gates S, Davies P, Chen IL, Todd I, et al. Life-threatening hypersensitivity pneumonitis secondary to ecigarettes. Arch Dis Child 2020; 105: 1114-6.
Casanova GS, Amaro R, Soler N, Sanchez M, Badia JR, Barbera JA, et al. An imported case of e-cigarette or vaping associated lung injury in Barcelona. Eur Respir J 2020; 55.
Marliere C, De Greef J, Gohy S, Hoton D, Wallemacq P, Jacquet LM, et al. Fatal e-cigarette or vaping associated lung injury (EVALI): a first case report in Europe. Eur Respir J 2020; 56.
Itoh M, Aoshiba K, Herai Y, Nakamura H, Takemura T. Lung injury associated with electronic cigarettes inhalation diagnosed by transbronchial lung biopsy. Respirol Case Rep 2018; 6: e00282.
Viswam D, Trotter S, Burge PS, Walters GI. Respiratory failure caused by lipoid pneumonia from vaping e-cigarettes. BMJ Case Rep 2018; 2018.
Krishnasamy VP, Hallowell BD, Ko JY, Board A, Hartnett KP, Salvatore PP, et al. Update: Characteristics of a Nationwide Outbreak of E-cigarette, or Vaping, Product Use-Associated Lung Injury - United States, August 2019-January 2020. MMWR Morb Mortal Wkly Rep 2020; 69: 90-4.
Ghinai I, Navon L, Gunn JKL, Duca LM, Brister S, Love S, et al. Characteristics of Persons Who Report Using Only Nicotine-Containing Products Among Interviewed Patients with E-cigarette, or Vaping, Product Use-Associated Lung Injury - Illinois, August-December 2019. MMWR Morb Mortal Wkly Rep 2020; 69: 84-9.
Wang MP, Ho SY, Leung LT, Lam TH. Electronic Cigarette Use and Respiratory Symptoms in Chinese Adolescents in Hong Kong. JAMA Pediatr 2016; 170: 89-91.
McConnell R, Barrington-Trimis JL, Wang K, Urman R, Hong H, Unger J, et al. Electronic Cigarette Use and Respiratory Symptoms in Adolescents. Am J Respir Crit Care Med 2017; 195: 1043-9.
Cho JH, Paik SY. Association between Electronic Cigarette Use and Asthma among High School Students in South Korea. PLoS One 2016; 11: e0151022.
Xie W, Kathuria H, Galiatsatos P, Blaha MJ, Hamburg NM, Robertson RM, et al. Association of Electronic Cigarette Use With Incident Respiratory Conditions Among US Adults From 2013 to 2018. JAMA Netw Open 2020; 3: e2020816.
Wang JB, Olgin JE, Nah G, Vittinghoff E, Cataldo JK, Pletcher MJ, et al. Cigarette and e-cigarette dual use and risk of cardiopulmonary symptoms in the Health eHeart Study. PLoS One 2018; 13: e0198681.
Flacco ME, Fiore M, Acuti Martellucci C, Ferrante M, Gualano MR, Liguori G, et al. Tobacco vs. electronic cigarettes: absence of harm reduction after six years of follow-up. Eur Rev Med Pharmacol Sci 2020; 24: 3923-34.
Polosa R, Morjaria JB, Prosperini U, Busa B, Pennisi A, Malerba M, et al. COPD smokers who switched to e-cigarettes: health outcomes at 5-year follow up. Ther Adv Chronic Dis 2020; 11: 2040622320961617.
Maouche K, Medjber K, Zahm JM, Delavoie F, Terryn C, Coraux C, et al. Contribution of alpha7 nicotinic receptor to airway epithelium dysfunction under nicotine exposure. Proc Natl Acad Sci U S A 2013; 110: 4099-104.
Scott A, Lugg ST, Aldridge K, Lewis KE, Bowden A, Mahida RY, et al. Pro-inflammatory effects of e-cigarette vapour condensate on human alveolar macrophages. Thorax 2018; 73: 1161-9.
Mravec B, Tibensky M, Horvathova L, Babal P. E-Cigarettes and Cancer Risk. Cancer Prev Res (Phila) 2020; 13: 137-44.
Ghosh A, Coakley RC, Mascenik T, Rowell TR, Davis ES, Rogers K, et al. Chronic E-Cigarette Exposure Alters the Human Bronchial Epithelial Proteome. Am J Respir Crit Care Med 2018; 198: 67-76.
Chaumont M, van de Borne P, Bernard A, Van Muylem A, Deprez G, Ullmo J, et al. Fourth generation e-cigarette vaping induces transient lung inflammation and gas exchange disturbances: results from two randomized clinical trials. Am J Physiol Lung Cell Mol Physiol 2019; 316: L705-19.
Sassano MF, Davis ES, Keating JE, Zorn BT, Kochar TK, Wolfgang MC, et al. Evaluation of e-liquid toxicity using an open-source highthroughput screening assay. PLoS Biol 2018; 16: e2003904.
Bozier J, Rutting S, Xenaki D, Peters M, Adcock I, Oliver BG. Heightened response to e-cigarettes in COPD. ERJ Open Res 2019; 5: 00192-2018.
Hartmann-Boyce J, McRobbie H, Butler AR, Lindson N, Bullen C, Begh R, et al. Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev 2021; 9: CD010216.
Hajek P, Phillips-Waller A, Przulj D, Pesola F, Myers Smith K, Bisal N, et al. A Randomized Trial of E-Cigarettes versus Nicotine-Replacement Therapy. N Engl J Med 2019; 380: 629-37.
Anthenelli RM, Benowitz NL, West R, St Aubin L, McRae T, Lawrence D, et al. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial. The Lancet 2016; 387: 2507-20.